Latest News and Press Releases

MONTRÉAL, 14 janv. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») (TSXV : LOVE) (OTCQX : LOVFF) (FRA : 8CB0), producteur verticalement...

Cannara qualified for OTCQX trading in the U.S. and will release its Q1 2026 financial results on January 26, 2026

MONTRÉAL, 17 nov. 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») (TSXV : LOVE) (OTCQB : LOVFF) (FRA : 8CB0), producteur verticalement intégré...

Cannara Biotech to report Q4 and FY2025 results November 24, 2025 at 7:00 AM, and announces with sadness the passing of longtime board member Jack M. Kay.

60 Degrees Pharma reports 223% YoY revenue growth in Q3 2025; advances babesiosis programs with Tulane, Mount Sinai, and MUMS canine designation plans.

LEEF Brands reports Q3 2025 results: revenue up 24%, margins double, cash flow positive, and strong growth from California and New York operations.

60 Degrees Pharma (Nasdaq: SXTP) Q2 2025: Supply issue cut revenue, profits rose from cash-pay sales; $1.97M cash extends runway to Mar 2026.

BEDFORD, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Legacy Housing Corporation (“Legacy” or the “Company,” NASDAQ: LEGH) today announced its financial results for the second quarter ended June 30,...

MONTRÉAL, 21 juill. 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») (TSXV : LOVE) (OTCQB : LOVFF) (FRA : 8CB0), producteur verticalement...

Cannara Biotech to announce fiscal Q3 2025 results on July 28, 2025